Thalidomide in primary peritoneal mesothelioma
β Scribed by Ghanashyam Biswas; Prasad Narayanan; Roshni Bhagwat; Alka Khadwal; Ashish V. Bakshi; Purvish M. Parikh
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 43 KB
- Volume
- 93
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background and Objectives: Primary Diffuse Malignant Peritoneal Mesothelioma is a rare disease, with an incidence of 2.2 cases in 1.000.000 in the USA. It occupies 10% of all mesotheliomas referred in literature. Methods: We describe a case of diffuse malignant peritoneal mesothelioma arising in a 5
## Abstract In some populationβbased studies, a shorter median survival was observed in peritoneal as compared with pleural, malignant mesothelioma, but in others, longer median survival times or higher proportions of longβterm survivors were reported. Statistical instability could have caused thes